Anna Farago - Publications

Affiliations: 
Semmelweis Egyetem, Hungary 
Area:
Cell Biology, Molecular Biology, Biochemistry

51 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Farago AF, Demetri GD. Larotrectinib, a selective tropomyosin receptor kinase inhibitor for adult and pediatric tropomyosin receptor kinase fusion cancers. Future Oncology (London, England). PMID 32129093 DOI: 10.2217/fon-2019-0647  0.391
2015 Farago AF, Le LP, Zheng Z, Muzikansky A, Drilon A, Patel M, Bauer TM, Liu SV, Ou SI, Jackman D, Costa DB, Multani PS, Li GG, Hornby Z, Chow-Maneval E, et al. Durable Clinical Response to Entrectinib in NTRK1-Rearranged Non-Small Cell Lung Cancer. Journal of Thoracic Oncology : Official Publication of the International Association For the Study of Lung Cancer. PMID 26565381 DOI: 10.1097/01.JTO.0000473485.38553.f0  0.351
2015 Burris HA, Brose MS, Shaw AT, Bauer TM, Farago AF, Doebele RC, Smith S, Fernandes M, Cruickshank S, Low JA. A first-in-human study of LOXO-101, a highly selective inhibitor of the tropomyosin receptor kinase (TRK) family. Journal of Clinical Oncology. 33: TPS2624-TPS2624. DOI: 10.1200/JCO.2015.33.15_SUPPL.TPS2624  0.337
2006 Sipeki S, Bander E, Parker PJ, Faragó A. PKCalpha reduces the lipid kinase activity of the p110alpha/p85alpha PI3K through the phosphorylation of the catalytic subunit. Biochemical and Biophysical Research Communications. 339: 122-5. PMID 16297884 DOI: 10.1016/J.Bbrc.2005.10.194  0.674
2004 Gujdár A, Sipeki S, Bander E, Buday L, Faragó A. Protein kinase C modulates negatively the hepatocyte growth factor-induced migration, integrin expression and phosphatidylinositol 3-kinase activation. Cellular Signalling. 16: 505-13. PMID 14709339 DOI: 10.1016/J.Cellsig.2003.09.009  0.721
2003 Gujdár A, Sipeki S, Bander E, Buday L, Faragó A. Phorbol ester-induced migration of HepG2 cells is accompanied by intensive stress fibre formation, enhanced integrin expression and transient down-regulation of p21-activated kinase 1. Cellular Signalling. 15: 307-18. PMID 12531429 DOI: 10.1016/S0898-6568(02)00087-6  0.722
2003 Tamás P, Solti Z, Bauer P, Illés A, Sipeki S, Bauer A, Faragó A, Downward J, Buday L. Mechanism of epidermal growth factor regulation of Vav2, a guanine nucleotide exchange factor for Rac. The Journal of Biological Chemistry. 278: 5163-71. PMID 12454019 DOI: 10.1074/Jbc.M207555200  0.622
2002 Sipeki S, Bander E, Ways DK, Faragó A. Activation of Erk1/Erk2 and transiently increased p53 levels together may account for p21 expression associated with phorbol ester-induced transient growth inhibition in HepG2 cells. Cellular Signalling. 14: 115-21. PMID 11781135 DOI: 10.1016/S0898-6568(01)00229-7  0.566
2000 Sipeki S, Bander E, Farkas G, Gujdár A, Ways DK, Faragó A. Protein kinase C decreases the hepatocyte growth factor-induced activation of Erk1/Erk2 MAP kinases. Cellular Signalling. 12: 549-55. PMID 11027948 DOI: 10.1016/S0898-6568(00)00105-4  0.731
1999 Sipeki S, Bander E, Buday L, Farkas G, Bácsy E, Ways DK, Faragó A. Phosphatidylinositol 3-kinase contributes to Erk1/Erk2 MAP kinase activation associated with hepatocyte growth factor-induced cell scattering. Cellular Signalling. 11: 885-90. PMID 10659996 DOI: 10.1016/S0898-6568(99)00060-1  0.665
1999 Wunderlich L, Gohér A, Faragó A, Downward J, Buday L. Requirement of multiple SH3 domains of Nck for ligand binding. Cellular Signalling. 11: 253-62. PMID 10372803 DOI: 10.1016/S0898-6568(98)00054-0  0.404
1999 Wunderlich L, Faragó A, Downward J, Buday L. Association of Nck with tyrosine-phosphorylated SLP-76 in activated T lymphocytes. European Journal of Immunology. 29: 1068-75. PMID 10229072 DOI: 10.1002/(Sici)1521-4141(199904)29:04<1068::Aid-Immu1068>3.0.Co;2-P  0.523
1999 Wunderlich L, Faragó A, Buday L. Characterization of interactions of Nck with Sos and dynamin. Cellular Signalling. 11: 25-9. PMID 10206341 DOI: 10.1016/S0898-6568(98)00027-8  0.334
1997 Mócsai A, Bánfi B, Kapus A, Farkas G, Geiszt M, Buday L, Faragó A, Ligeti E. Differential effects of tyrosine kinase inhibitors and an inhibitor of the mitogen-activated protein kinase cascade on degranulation and superoxide production of human neutrophil granulocytes. Biochemical Pharmacology. 54: 781-9. PMID 9353132 DOI: 10.1016/S0006-2952(97)00245-1  0.648
1996 Mihalik R, Farkas G, Kopper L, Benczúr M, Faragó A. Possible involvement of protein kinase C-epsilon in phorbol ester-induced growth inhibition of human lymphoblastic cells. The International Journal of Biochemistry & Cell Biology. 28: 925-33. PMID 8811841 DOI: 10.1016/1357-2725(96)00020-9  0.538
1996 Buday L, Khwaja A, Sipeki S, Faragó A, Downward J. Interactions of Cbl with two adapter proteins, Grb2 and Crk, upon T cell activation. The Journal of Biological Chemistry. 271: 6159-63. PMID 8626404 DOI: 10.1074/Jbc.271.11.6159  0.543
1994 Farkas G, Buday L, Csermely P, Faragó A. Lipocortin I is not accessible for protein kinase C bound to the cytoplasmic surface of the plasma membrane in streptolysin-O-permeabilized pig granulocytes. Biochimica Et Biophysica Acta. 1220: 315-22. PMID 8305505 DOI: 10.1016/0167-4889(94)90155-4  0.554
1994 Bauer PI, Farkas G, Mihalik R, Kopper L, Kun E, Faragó A. Phosphorylation of poly(ADP-ribose)polymerase protein in human peripheral lymphocytes stimulated with phytohemagglutinin. Biochimica Et Biophysica Acta. 1223: 234-9. PMID 8086493 DOI: 10.1016/0167-4889(94)90231-3  0.652
1992 Buday L, Farkas G, Faragó A. Synthetic oligopeptide substrates which fail to compete with H1 histone for type II and type III isoenzymes of protein kinase C. The International Journal of Biochemistry. 24: 777-82. PMID 1592153 DOI: 10.1016/0020-711X(92)90011-O  0.495
1992 Hajnóczky G, Várnai P, Buday L, Faragó A, Spät A. The role of protein kinase-C in control of aldosterone production by rat adrenal glomerulosa cells: activation of protein kinase-C by stimulation with potassium. Endocrinology. 130: 2230-6. PMID 1547736 DOI: 10.1210/Endo.130.4.1547736  0.547
1992 Bauer PI, Farkas G, Buday L, Mikala G, Meszaros G, Kun E, Farago A. Inhibition of DNA binding by the phosphorylation of poly ADP-ribose polymerase protein catalysed by protein kinase C. Biochemical and Biophysical Research Communications. 187: 730-6. PMID 1530631 DOI: 10.1016/0006-291X(92)91256-P  0.61
1991 Farkas G, Buday L, Antoni F, Faragó A. The 38 kDa Ca2+/membrane-binding protein of pig granulocytes needs a high Ca2+ concentration to be phosphorylated by protein kinase C. Biochimica Et Biophysica Acta. 1091: 81-6. PMID 1995069 DOI: 10.1016/0167-4889(91)90225-M  0.6
1990 Farago A, Nishizuka Y. Protein kinase C in transmembrane signalling. Febs Letters. 268: 350-4. PMID 2200716 DOI: 10.1016/0014-5793(90)81284-U  0.458
1990 Buday L, Faragó A. Dual effect of arachidonic acid on protein kinase C isoenzymes isolated from rabbit thymus cells. Febs Letters. 276: 223-6. PMID 2125008 DOI: 10.1016/0014-5793(90)80547-V  0.489
1989 Olah Z, Bogre L, Lehel C, Farago A, Seprodi J, Dudits D. The phosphorylation site of Ca(2+)-dependent protein kinase from alfalfa. Plant Molecular Biology. 12: 453-61. PMID 24272905 DOI: 10.1007/Bf00017584  0.615
1989 Faragó A, Farkas G, Mészáros G, Buday L, Antoni F, Seprödi J. Isoenzyme patterns of protein kinase C and a phospholipid-dependent but Ca2+-inhibited enzyme fraction in the crude extracts of different tissues. Febs Letters. 243: 328-32. PMID 2917653 DOI: 10.1016/0014-5793(89)80155-3  0.529
1989 Buday L, Mészáros G, Farkas G, Seprödi J, Antoni F, Faragó A. Two components of type III protein kinase C with different substrate specificities and a phospholipid-dependent but Ca2+-inhibited protein kinase in rat brain. Febs Letters. 249: 324-8. PMID 2544454 DOI: 10.1016/0014-5793(89)80651-9  0.616
1988 Faragó A, Seprõdi J, Spät A. Subcellular distribution of protein kinase C in rat adrenal glomerulosa cells. Biochemical and Biophysical Research Communications. 156: 628-33. PMID 3190673 DOI: 10.1016/S0006-291X(88)80889-1  0.62
1988 Mandl J, Mucha I, Bánhegyi G, Mészáros G, Faragó A, Spolarics Z, Machovich R, Antoni F, Garzó T. cAMP dependent inhibition of thromboxane A2, prostacyclin and PGF2 alpha synthesis in mouse hepatocytes. Prostaglandins. 36: 761-72. PMID 2854284 DOI: 10.1016/0090-6980(88)90054-8  0.509
1988 Bánhegyi G, Garzó T, Mészáros G, Faragó A, Antoni F, Mandl J. Cyclic AMP-dependent phosphorylation in the control of biotransformation in the liver. Biochemical Pharmacology. 37: 849-54. PMID 2830884 DOI: 10.1016/0006-2952(88)90171-2  0.435
1987 Buday L, Seprödi J, Farkas G, Mészáros G, Romhányi T, Bánhegyi G, Mandl J, Antoni F, Faragó A. Proteolytic activation of protein kinase C in the extracts of cells treated for a short time with phorbol ester. Febs Letters. 223: 15-9. PMID 3666136 DOI: 10.1016/0014-5793(87)80501-X  0.652
1986 Romhányi T, Seprödi J, Antoni F, Mészáros G, Buday L, Faragó A. The assay of the activity of protein kinase C with the synthetic oligopeptide substrate designed for histone kinase II. Biochimica Et Biophysica Acta. 888: 325-31. PMID 3019424 DOI: 10.1016/0167-4889(86)90232-6  0.616
1985 Romhányi T, Seprödi J, Antoni F, Mészáros G, Faragó A. Specific substrate for histone kinase II: a synthetic nonapeptide. Biochimica Et Biophysica Acta. 827: 144-9. PMID 2981556 DOI: 10.1016/0167-4838(85)90083-4  0.449
1984 Farkas G, Enyedi A, Sarkadi B, Gárdos G, Nagy Z, Faragó A. Cyclic AMP-dependent protein kinase stimulates the phosphorylation of phosphatidylinositol to phosphatidylinositol-4-monophosphate in a plasma membrane preparation from pig granulocytes. Biochemical and Biophysical Research Communications. 124: 871-6. PMID 6095827 DOI: 10.1016/0006-291X(84)91038-6  0.513
1984 Enyedi A, Faragó A, Sarkadi B, Gárdos G. Cyclic AMP-dependent protein kinase and Ca2+-calmodulin stimulate the formation of polyphosphoinositides in a sarcoplasmic reticulum preparation of rabbit heart. Febs Letters. 176: 235-8. PMID 6092135 DOI: 10.1016/0014-5793(84)80948-5  0.524
1983 Enyedi A, Faragó A, Sarkadi B, Szász I, Gárdos G. Cyclic AMP-dependent protein kinase stimulates the formation of polyphosphoinositides in the plasma membranes of different blood cells. Febs Letters. 161: 158-62. PMID 6309575 DOI: 10.1016/0014-5793(83)80751-0  0.549
1983 Sarkadi B, Enyedi A, Faragó A, Mészáros G, Kremmer T, Gárdos G. Cyclic AMP-dependent protein kinase stimulates the formation of polyphosphoinositides in lymphocyte plasma membrane. Febs Letters. 152: 195-8. PMID 6297997 DOI: 10.1016/0014-5793(83)80378-0  0.537
1982 Romhányi T, Seprödi J, Mészáros G, Antoni F, Faragó A. The intrinsic substrate specificity of a cyclic nucleotide-independent protein (histone) kinase. Febs Letters. 144: 223-5. PMID 6288470 DOI: 10.1016/0014-5793(82)80642-X  0.547
1982 Romhányi T, Seprödi J, Antoni F, Nikolics K, Mészáros G, Faragó A. The site of histone H2b phosphorylated by a cyclic nucleotide independent histone kinase. Biochimica Et Biophysica Acta. 701: 57-62. PMID 6275900 DOI: 10.1016/0167-4838(82)90312-0  0.537
1981 Mészáros G, Romhányi T, Antoni F, Faragó A. Subcellular distribution of the subunits of cyclic AMP-dependent protein kinase isoenzymes in human tonsillar lymphocytes. Febs Letters. 134: 139-42. PMID 6273229 DOI: 10.1016/0014-5793(81)80586-8  0.522
1981 Faragó A, Mészáros G, Antoni F. SUBCELLULAR. DISTRIBUTION OF THE SUBUNITS OF cAMP-DEPENDENT PROTEIN KINASE ISOENZYMES IN HUMAN TONSILLAR LYMPHOCYTES Biochemical Society Transactions. 9. DOI: 10.1042/Bst009232Pe  0.555
1980 Faragó A, Hang PL, Mészáros G, Antoni F. Low molecular weight cyclic AMP binding protein isolated from the extract of human tonsillar lymphocytes. Biochimica Et Biophysica Acta. 632: 649-60. PMID 6254578 DOI: 10.1016/0304-4165(80)90340-2  0.404
1979 Takáts A, Antoni F, Faragó A. Cyclic nucleotide binding properties and molecular forms of the cyclic-AMP-dependent protein kinase from bovine eye lens. Biochimica Et Biophysica Acta. 568: 475-83. PMID 226149 DOI: 10.1016/0005-2744(79)90316-4  0.477
1979 Takáts A, Antoni F, Faragó A. Changes of the cAMP-dependent protein kinases during differentiation of lens cells Ophthalmic Research. 11: 366-371. DOI: 10.1159/000265035  0.545
1978 Takáts A, Antoni F, Faragó A, Kertész P. Some properties of the cyclic AMP dependent protein kinase of epithelial cells and cortical fibers of bovine eye lens. Experimental Eye Research. 26: 389-97. PMID 205426 DOI: 10.1016/0014-4835(78)90126-4  0.469
1978 Faragó A, Hasznos P, Antoni F, Romhányi T. Two types of cyclic GMP binding site associated with the cyclic AMP-dependent protein kinase from lymphocytes. Biochimica Et Biophysica Acta. 538: 493-504. PMID 203328 DOI: 10.1016/0304-4165(78)90410-5  0.373
1975 Farago A, Romhanyi T, Antoni F, Takats A, Fabian F. The phosphorylated site of calf thymus F2b histone by the cyclic AMP-dependent protein kinase. Nature. 254: 88. PMID 163445 DOI: 10.1038/254088A0  0.564
1974 Faragó A, Antoni F, Fábián F. Histone kinases and cyclic AMP-binding capacity of nuclei of human tonsillar lymphocytes. Biochimica Et Biophysica Acta. 370: 459-67. PMID 4374243 DOI: 10.1016/0005-2744(74)90107-7  0.611
1973 Faragó A, Antoni F, Takáts A, Fábián F. Adenosine 3′:5′-monophosphate-dependent an independent histone kinases isolated from human tonsillar lymphocytes Biochimica Et Biophysica Acta. 297: 517-526. DOI: 10.1016/0304-4165(73)90099-8  0.475
1972 Takáts A, Faragó A, Antoni F. Adenosine 3':5'-monophosphate dependent protein kinase in the lacrymal gland. Biochimica Et Biophysica Acta. 268: 77-80. PMID 4336172 DOI: 10.1016/0005-2744(72)90199-4  0.534
1969 Faragó A, Dénes G. Differences between the active and the inhibited conformations of the allosteric N-acetylglutamate 5-phosphotransferase. Biochimica Et Biophysica Acta. 178: 400-2. PMID 5772415 DOI: 10.1016/0005-2744(69)90411-2  0.32
Show low-probability matches.